Literature DB >> 25476912

Aortic dissection in patients with autosomal dominant polycystic kidney disease: a series of two cases and a review of the literature.

Angelo Silverio1, Costantina Prota, Marco Di Maio, Maria Vincenza Polito, Francesco Maria Cogliani, Rodolfo Citro, Alberto Gigantino, Severino Iesu, Federico Piscione.   

Abstract

Aortic dissection (AD) is the most common life-threatening disease involving the aorta. It is rarely associated with systemic disorders such as Autosomal Dominant Polycystic Kidney Disease (ADPKD), a genetic syndrome characterized by cystic degeneration of kidneys, possible presence of cysts in other organs and extra-renal manifestations, including cardiovascular disorders. We performed a systematic literature search focused on the occurrence of AD associated with ADPKD (25 cases identified), and reported two cases from our experience. We selected data on sex, age, family history of ADPKD and/or AD, habitus, hypertension, renal function, presence of hepatic/pancreatic/splenic cysts, clinical presentation of AD, AD type according to the Stanford classification, treatment and outcome. Furthermore we compared this dataset with the data of the overall population with AD from the International Registry of Acute Aortic Dissection (IRAD). Stanford A type AD was documented in 62% of patients. As expected, the initial manifestation of AD was most commonly chest and back pain (80%). The mean age of AD occurrence appears significantly reduced in ADPKD patients compared to the general population with AD (49 ± 12 vs 62 ± 14, P < 0.001). Of note, our analysis shows a remarkably higher frequency of hypertension (90%) compared to the overall AD population (75%), although not significantly (P = 0.133). AD should be always ruled out in ADPKD subjects with chest and back pain symptoms, despite them being young and at lower risk. A careful preventive monitoring as well as an optimal blood pressure control may reduce the risk of AD and improve the outcome of these patients.
© 2014 Asian Pacific Society of Nephrology.

Entities:  

Keywords:  aortic dissection; autosomal dominant policystic kidney disease; chronic kidney disease; hypertension

Mesh:

Year:  2015        PMID: 25476912     DOI: 10.1111/nep.12373

Source DB:  PubMed          Journal:  Nephrology (Carlton)        ISSN: 1320-5358            Impact factor:   2.506


  8 in total

Review 1.  Syndromes with aortic involvement: pictorial review.

Authors:  Evan J Zucker
Journal:  Cardiovasc Diagn Ther       Date:  2018-04

2.  Aortic dilatation in children with mild to moderate chronic kidney disease.

Authors:  Peace C Madueme; Derek K Ng; Luke Guju; Lauren Longshore; Vicky Moore; Lynn Jefferies; Bradley A Warady; Susan Furth; Mark Mitsnefes
Journal:  Pediatr Nephrol       Date:  2020-01-15       Impact factor: 3.714

3.  Catastrophic extrarenal manifestation of autosomal dominant polycystic kidney disease: lessons learnt.

Authors:  Yousif Mohamed Hydoub; Maryam Alnuaimi; Seema Nour
Journal:  BMJ Case Rep       Date:  2019-12-23

4.  Risk of aortic aneurysm and dissection in patients with autosomal-dominant polycystic kidney disease: a nationwide population-based cohort study.

Authors:  Pei-Hsun Sung; Yao-Hsu Yang; Hsin-Ju Chiang; John Y Chiang; Chi-Jen Chen; Chien-Ting Liu; Cheuk-Man Yu; Hon-Kan Yip
Journal:  Oncotarget       Date:  2017-03-17

5.  Aortic Dissection in Familial Patients with Autosomal Dominant Polycystic Kidney Disease.

Authors:  Yu Inaba; Motohiko Osako; Michiko Aoki; Mio Kasai; Kentaro Yamabe
Journal:  Ann Vasc Dis       Date:  2021-03-25

6.  Aortic dissection in Indonesia male: 3 case report.

Authors:  Mustika Cakti Anggraini; Anita Widyoningroem
Journal:  Ann Med Surg (Lond)       Date:  2022-03-03

7.  Successful Endovascular Stent-Graft Repair for Complicated Type B Aortic Dissection Developed in a Patient with Polycystic Kidney Disease.

Authors:  Chan Sung Jung; Byoung-Won Park; Duk Won Bang; Won Ho Jang; Hyo Shik Kim; Ji Hyun Oh
Journal:  Vasc Specialist Int       Date:  2015-06-30

8.  Whole exome sequencing reveals a stop-gain mutation of PKD2 in an autosomal dominant polycystic kidney disease family complicated with aortic dissection.

Authors:  Wenwen Zhang; Qian Han; Zhao Liu; Wei Zhou; Qing Cao; Weimin Zhou
Journal:  BMC Med Genet       Date:  2018-01-30       Impact factor: 2.103

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.